Abstract
Emphysematous gastritis is a life-threatening disease. It is characterized by the presence of gas within the wall of the stomach. The etiology includes firstly infections with gas-forming organisms; other predisposing causes are the ingestion of corrosive substances and alcohol abuse. Diagnosis is based on radiological techniques, mainly computed tomographic scan (CT). The election treatment is antibiotics and surgery. The evolution is generally fatal. We present the first known case reported, which is associated with aplastic anemia with immunosuppressive therapy, its evolution with medical treatment and a literature review.
MeSH terms
-
Anemia, Aplastic / complications*
-
Anemia, Aplastic / drug therapy
-
Antilymphocyte Serum / therapeutic use
-
Cholelithiasis / complications
-
Cyclosporine / therapeutic use
-
Emphysema / complications*
-
Emphysema / diagnostic imaging
-
Female
-
Gastritis / complications*
-
Gastritis / diagnostic imaging
-
Granulocyte Colony-Stimulating Factor / therapeutic use
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Meropenem
-
Methylprednisolone / therapeutic use
-
Metronidazole / therapeutic use
-
Middle Aged
-
T-Lymphocytes
-
Thienamycins / therapeutic use
-
Tomography, X-Ray Computed
Substances
-
Antilymphocyte Serum
-
Immunosuppressive Agents
-
Thienamycins
-
Metronidazole
-
Granulocyte Colony-Stimulating Factor
-
Cyclosporine
-
Meropenem
-
Methylprednisolone